Does labetalol increase excretion of urinary catecholamines?
作者信息
Hamilton C A, Jones D H, Dargie H J, Reid J L
出版信息
Br Med J. 1978 Sep 16;2(6140):800. doi: 10.1136/bmj.2.6140.800.
Abstract
摘要
相似文献
1
Does labetalol increase excretion of urinary catecholamines?拉贝洛尔会增加尿儿茶酚胺的排泄吗？
Br Med J. 1978 Sep 16;2(6140):800. doi: 10.1136/bmj.2.6140.800.
2
Labetalol and determination of pressor hormones.
Ann Intern Med. 1984 Feb;100(2):314. doi: 10.7326/0003-4819-100-2-314_1.
3
Increased catecholamine excretion after labetalol therapy: a spurious effect of drug metabolites.
Clin Chim Acta. 1979 Jul 16;95(2):211-7. doi: 10.1016/0009-8981(79)90361-9.
4
Urinary catecholamines and labetalol.
Arch Int Pharmacodyn Ther. 1978 Dec;236(2):317-9.
5
Falsely elevated urinary excretion of catecholamines and metanephrines in patients receiving labetalol therapy.
J Clin Pharmacol. 1987 Apr;27(4):288-92. doi: 10.1002/j.1552-4604.1987.tb03015.x.
6
[Effect of labetalol on the excretion of catecholamines and their metabolites in primary hypertension].
Pol Tyg Lek. 1981 Aug 31;36(35):1337-9.
7
Labetalol and urinary catecholamines.拉贝洛尔与尿儿茶酚胺
Br Med J. 1977;2(6103):1673. doi: 10.1136/bmj.2.6103.1673-a.
8
Labetalol and urinary catecholamines.
Br Med J. 1979 Mar 10;1(6164):685. doi: 10.1136/bmj.1.6164.685-c.
9
Labetalol and urinary catecholamines.拉贝洛尔与尿儿茶酚胺
Br Med J. 1979 Jan 27;1(6158):268-9. doi: 10.1136/bmj.1.6158.268-d.
10
Labetalol and urinary catecholamines.
Br Med J. 1978 Feb 11;1(6109):364. doi: 10.1136/bmj.1.6109.364-a.
引用本文的文献
1
Neurogenic aspects of essential hypertension in man.人类原发性高血压的神经源性因素
Ir J Med Sci. 1979 Dec;148(1):280-9. doi: 10.1007/BF02938100.
2
Effects of chronic alpha and beta adrenoceptor blockade with labetalol on plasma catecholamines and renal function in hypertension.拉贝洛尔长期α和β肾上腺素能受体阻滞对高血压患者血浆儿茶酚胺及肾功能的影响
Klin Wochenschr. 1980 Jan 2;58(1):25-9. doi: 10.1007/BF01477140.
3
Use of labetalol in hypertensive patients during discontinuation of clonidine therapy.可乐定治疗停药期间拉贝洛尔在高血压患者中的应用。
Eur J Clin Pharmacol. 1981;20(4):237-40. doi: 10.1007/BF00618771.
4
Pharmacology of combined alpha-beta-blockade. I.α-β联合阻滞的药理学。I.
Drugs. 1984;28 Suppl 2:16-34. doi: 10.2165/00003495-198400282-00003.
5
Erroneous diagnosis of phaeochromocytoma in hypertensive patient on labetalol.使用拉贝洛尔治疗的高血压患者嗜铬细胞瘤的误诊
J R Soc Med. 1985 Jul;78(7):588-9. doi: 10.1177/014107688507800713.
6
Ventricular myosin pattern of spontaneously hypertensive turkeys is unaffected by labetalol treatment.拉贝洛尔治疗对自发性高血压火鸡的心室肌球蛋白模式无影响。
Basic Res Cardiol. 1988 May-Jun;83(3):277-85. doi: 10.1007/BF01907361.
7
Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.拉贝洛尔，一种α和β肾上腺素能受体阻滞剂：其在治疗中的应用。研讨会综述。
Br J Clin Pharmacol. 1979;8(Suppl 2):239S-244S.
8
Effect of oral labetalol on plasma catecholamines, renin and aldosterone in patients with severe arterial hypertension.口服拉贝洛尔对重度动脉高血压患者血浆儿茶酚胺、肾素和醛固酮的影响。
Eur J Clin Pharmacol. 1979 Nov;16(5):305-10. doi: 10.1007/BF00605626.
9
A long-term study of labetalol in general practice.拉贝洛尔在全科医疗中的长期研究。
Br J Clin Pharmacol. 1979;8(Suppl 2):167S-170S.
本文引用的文献
1
Improved technique for the fluorimetric estimation of catecholamines.儿茶酚胺荧光测定的改进技术。
Acta Physiol Scand. 1961 Apr;51:348-55. doi: 10.1111/j.1748-1716.1961.tb02128.x.
2
Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range.飞摩尔范围内血浆和组织中肾上腺素、去甲肾上腺素及多巴胺的同步放射酶法测定
Life Sci. 1976 Oct 15;19(8):1161-74. doi: 10.1016/0024-3205(76)90251-4.
3
Labetalol and urinary catecholamines.
Br Med J. 1978 Feb 11;1(6109):364. doi: 10.1136/bmj.1.6109.364-a.
Zotero 插件